Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the HepatoPredict Prognostic Tool in the Decision of Liver Transplant in Hepatocellular Carcinoma

NCT04499833 is registered in ClinicalTrials.gov with Centro Hospitalar de Lisboa Central as lead sponsor.

NCT NCT04499833
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04499833 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the HepatoPredict Prognostic Tool in the Decision of Liver Transplant in Hepatocellular Carcinoma
Lead sponsor
Centro Hospitalar de Lisboa Central
Phase
Not applicable
Overall status
Recruiting
Start date
March 25, 2021
Completion date
December 31, 2029
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma, scirrhous, recurrence tumor